Yatin Suneja Guggenheim Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
52
Avg Return
Past Year
Past Year
74%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $32 |
34%
upside
| 1 | +210% |
0
%
| 7 Jan ‘26 11 days ago |
|
|
|
Buy
Initiated
| $15 |
277%
upside
| 1 | +0.76% |
0
%
| 19 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $51 |
145%
upside
| 2 | +27% |
0
%
| 17 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $760 |
140%
upside
| 1 | +42% |
0
%
| 9 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $22 |
2,100%
upside
| 1 | -13% |
0
%
| 10 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $100 |
119%
upside
| 1 | +34% |
0
%
| 5 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $205 |
16%
upside
| 1 | +31% |
0
%
| 4 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $865 |
18%
upside
| 1 | +7.5% |
0
%
| 29 Oct ‘25 2 months ago |
|
|
|
Buy
Upgraded
| $14 |
593%
upside
| 1 | -23% |
0
%
| 27 Oct ‘25 2 months ago |
|
|
|
Buy
Initiated
| $70 |
99%
upside
| 1 | +19% |
0
%
| 27 Oct ‘25 2 months ago |
|
|
|
Buy
Initiated
| $60 |
80%
upside
| 1 | -1.4% |
0
%
| 27 Oct ‘25 2 months ago |
|